tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Relay Therapeutics Reports Q2 2025 Financial Results and Progress
PremiumCompany AnnouncementsRelay Therapeutics Reports Q2 2025 Financial Results and Progress
1M ago
Relay Therapeutics reports Q2 EPS (41c), consensus (47c)
Premium
The Fly
Relay Therapeutics reports Q2 EPS (41c), consensus (47c)
1M ago
Relay Therapeutics’ Phase 3 Study: A New Hope for Advanced Breast Cancer Treatment
Premium
Company Announcements
Relay Therapeutics’ Phase 3 Study: A New Hope for Advanced Breast Cancer Treatment
1M ago
Relay Therapeutics announces updated data for RLY-2608 with Fulvestrant
PremiumThe FlyRelay Therapeutics announces updated data for RLY-2608 with Fulvestrant
3M ago
Relay Therapeutics price target lowered to $10 from $30 at Guggenheim
Premium
The Fly
Relay Therapeutics price target lowered to $10 from $30 at Guggenheim
4M ago
3 Best Stocks to Buy Now, 5/7/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 5/7/2025, According to Top Analysts
4M ago
Is RLAY a Buy, Before Earnings?
PremiumPre-EarningsIs RLAY a Buy, Before Earnings?
4M ago
Relay Therapeutics initiated with an Equal Weight at Wells Fargo
Premium
The Fly
Relay Therapeutics initiated with an Equal Weight at Wells Fargo
5M ago
Strategic Operational Changes and Financial Stability Bolster Relay Therapeutics’ Buy Rating
Premium
Ratings
Strategic Operational Changes and Financial Stability Bolster Relay Therapeutics’ Buy Rating
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100